Functional effects of expression of wolframin-antisense transcripts in BRIN-BD11 β-cells

被引:7
作者
McBain, SC
Morgan, NG
机构
[1] Peninsula Med Sch, Inst Biomed & Clin Sci, Plymouth PL6 8BX, Devon, England
[2] Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England
基金
英国生物技术与生命科学研究理事会;
关键词
Islets of Langerhans; Wolfram syndrome; pancreatic beta-cell; proliferation; insulin secretion; DIDMOAD;
D O I
10.1016/S0006-291X(03)01243-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wolfram syndrome is a rare condition in which the pancreatic beta-cells of patients are selectively deleted during the early years of life by a non-autoimmune-mediated mechanism. The condition is associated with mutations in the gene encoding wolframin, suggesting that this protein exerts a critical, but currently unknown, function in beta-cells. We have used an antisense strategy to modulate the expression of wolframin in insulin-secreting BRIN-BD11 cells to study its function. Stably transfected clones were established expressing full-length human wolframin antisense transcripts. These cells exhibited a dramatic reduction in cell proliferation rate and changes in morphology, although insulin secretion was not modified. The results imply that wolframin expression is required to sustain normal rates of beta-cell proliferation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:684 / 688
页数:5
相关论文
共 18 条
[1]   NEURODEGENERATION AND DIABETES - UK NATIONWIDE STUDY OF WOLFRAM (DIDMOAD) SYNDROME [J].
BARRETT, TG ;
BUNDEY, SE ;
MACLEOD, AF .
LANCET, 1995, 346 (8988) :1458-1463
[2]   Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes [J].
Barrett, TG .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 15 (03) :325-343
[3]   A novel approach to increase human islet cell mass while preserving β-cell function [J].
Beattie, GM ;
Montgomery, AMP ;
Lopez, AD ;
Hao, E ;
Perez, B ;
Just, ML ;
Lakey, JRT ;
Hart, ME ;
Hayek, A .
DIABETES, 2002, 51 (12) :3435-3439
[4]   β-cell turnover -: Its assessment and implications [J].
Bonner-Weir, S .
DIABETES, 2001, 50 :S20-S24
[5]   β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes [J].
Butler, AE ;
Janson, J ;
Bonner-Weir, S ;
Ritzel, R ;
Rizza, RA ;
Butler, PC .
DIABETES, 2003, 52 (01) :102-110
[6]   WFS1 mutations in Spanish patients with diabetes mellitus and deafness [J].
Domènech, E ;
Gómez-Zaera, M ;
Nunes, V .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (07) :421-426
[7]   Reflexions on a newly discovered diabetogenic gene, wolframin (WFS1) [J].
Gerbitz, KD .
DIABETOLOGIA, 1999, 42 (05) :627-630
[8]   Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1 [J].
Hardy, C ;
Khanim, F ;
Torres, R ;
Scott-Brown, M ;
Seller, A ;
Poulton, J ;
Collier, D ;
Kirk, J ;
Polymeropoulos, M ;
Latif, F ;
Barrett, T .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (05) :1279-1290
[9]   A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) [J].
Inoue, H ;
Tanizawa, Y ;
Wasson, J ;
Behn, P ;
Kalidas, K ;
Bernal-Mizrachi, E ;
Mueckler, M ;
Marshall, H ;
Donis-Keller, H ;
Crock, P ;
Rogers, D ;
Mikuni, M ;
Kumashiro, H ;
Higashi, K ;
Sobue, G ;
Oka, Y ;
Permutt, MA .
NATURE GENETICS, 1998, 20 (02) :143-148
[10]  
Ishihara H, 2003, DIABETES, V52, pA42